Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients (vol 72, pg 317, 2017)

Lucchetta, RC

Riveros, BS Pontarolo, R Radominski, RB Otuki, MF Fernandez-Llimos, F

Correr, CJ

Permalink

Open Access

Copyright Clearance Process

This item is open access.

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Lucchetta, RC https://orcid.org/0000-0002-4004-1320	en_US
dc.contributor.author	Riveros, BS	en_US
dc.contributor.author	Pontarolo, R	en_US
dc.contributor.author	Radominski, RB	en_US
dc.contributor.author	Otuki, MF	en_US
dc.contributor.author	Fernandez-Llimos, F https://orcid.org/0000-0002-8529-9595	en_US
dc.contributor.author	Correr, CJ	en_US
dc.date.issued	2018-01-01	en_US
dc.identifier.citation	CLINICS, 2018, 73 pp. ? - ? (1)	en_US
dc.identifier.issn	1807-5932	en_US
dc.identifier.uri	http://hdl.handle.net/10453/131554
dc.language	English	en_US
dc.publisher	HOSPITAL CLINICAS, UNIV SAO PAULO	en_US
dc.relation.ispartof	CLINICS	en_US
dc.relation.isbasedon	10.6061/clinics/2018/e1err	en_US
dc.subject.classification	General Clinical Medicine	en_US
dc.title	Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients (vol 72, pg 317, 2017)	en_US
dc.type	Journal Article
utslib.citation.volume	73	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	open_access
pubs.publication-status	Published	en_US
pubs.volume	73	en_US

Please use this identifier to cite or link to this item: